2 Matching Annotations
  1. Jul 2018
    1. On 2014 Mar 09, Mao Mao commented:

      This is a cost-effective, single tube assay for screening all three lung cancer targetable gene fusions in NSCLC patients. We also report a novel RET fusion (CUX1-RET) in the paper.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

  2. Feb 2018
    1. On 2014 Mar 09, Mao Mao commented:

      This is a cost-effective, single tube assay for screening all three lung cancer targetable gene fusions in NSCLC patients. We also report a novel RET fusion (CUX1-RET) in the paper.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.